SCHEMBL1574073

SCHEMBL1574073

NC1CC2COCC(C1)N2C(=O)O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.30
GABRR1 P24046 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1574072 1.00 PTPN11 (0.30) PTPN11GABRR1
Trifluoroacetic Acid SCHEMBL15546542 0.89
SCHEMBL23149394 0.81 CHRM2 (0.35)
SCHEMBL20958513 0.81 CHRM2 (0.35)
SCHEMBL26906075 0.81 CHRM2 (0.35)
SCHEMBL26919745 0.81 CHRM2 (0.35)
SCHEMBL21777886 0.80 CHRM2 (0.33) GABRR1
SCHEMBL3528773 0.80 CHRM2 (0.33) GABRR1
SCHEMBL21777884 0.80 CHRM2 (0.33) GABRR1
SCHEMBL1574380 0.80 CHRM2 (0.33) GABRR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2875012-A1 5HT3 RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2015-05-27 EP disclosed
WO-2014014962-A1 5HT3 RECEPTOR ANTAGONISTS ENVOY THERAPEUTICS, INC. (US) 2014-01-23 WO disclosed
EP-1140085-B1 AZABICYCLOALKANES AS CCR5 MODULATORS PHIVCO UK LTD (GB) 2011-04-13 EP disclosed
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed